Global and Region Prophylactic Human Vaccines Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Prophylactic Human Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Prophylactic Human Vaccinesmarket, defines the market attractiveness level of Prophylactic Human Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Prophylactic Human Vaccines industry, describes the types of Prophylactic Human Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prophylactic Human Vaccines market and the development prospects and opportunities of Prophylactic Human Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prophylactic Human Vaccines market in Chapter 13.

    By Player:

    • ALK

    • Pfizer

    • Takeda Pharmaceutical Company

    • Bavarian Nordic

    • Shanghai BravoBio

    • Serum Institute of India

    • Altimmune

    • Bharat Biotech International

    • Hualan Biological Engineering

    • Sanofi Pasteur

    • Janssen Pharmaceuticals

    • BiondVax Pharmaceuticals

    • MedImmune

    • Merck

    • Seqirus

    • Zydus Cadila

    • GlaxoSmithKline

    • SK Chemicals

    By Type:

    • Type I

    • Type II

    By End-User:

    • Pediatric Prophylactic Vaccines

    • Adult Prophylactic Vaccines

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Prophylactic Human Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Prophylactic Human Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Prophylactic Human Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Prophylactic Human Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Prophylactic Human Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.2 United States Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.3 Europe Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.4 China Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.5 Japan Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.6 India Prophylactic Human Vaccines Consumption (2017-2022)

    • 7.7 South Korea Prophylactic Human Vaccines Consumption (2017-2022)

    8 Region and Country-wise Prophylactic Human Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Prophylactic Human Vaccines Consumption Forecast (2022-2028)

    9 Global Prophylactic Human Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Prophylactic Human Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type I Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type II Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prophylactic Human Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pediatric Prophylactic Vaccines Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult Prophylactic Vaccines Consumption and Growth Rate (2017-2022)

    10 Global Prophylactic Human Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Prophylactic Human Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type I Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type II Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Prophylactic Human Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pediatric Prophylactic Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Adult Prophylactic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    11 Global Prophylactic Human Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Prophylactic Human Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Prophylactic Human Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Prophylactic Human Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Prophylactic Human Vaccines Market Competitive Analysis

    • 14.1 ALK

      • 14.1.1 ALK Company Details

      • 14.1.2 ALK Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 ALK Prophylactic Human Vaccines Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Prophylactic Human Vaccines Product and Service

    • 14.3 Takeda Pharmaceutical Company

      • 14.3.1 Takeda Pharmaceutical Company Company Details

      • 14.3.2 Takeda Pharmaceutical Company Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Takeda Pharmaceutical Company Prophylactic Human Vaccines Product and Service

    • 14.4 Bavarian Nordic

      • 14.4.1 Bavarian Nordic Company Details

      • 14.4.2 Bavarian Nordic Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bavarian Nordic Prophylactic Human Vaccines Product and Service

    • 14.5 Shanghai BravoBio

      • 14.5.1 Shanghai BravoBio Company Details

      • 14.5.2 Shanghai BravoBio Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Shanghai BravoBio Prophylactic Human Vaccines Product and Service

    • 14.6 Serum Institute of India

      • 14.6.1 Serum Institute of India Company Details

      • 14.6.2 Serum Institute of India Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Serum Institute of India Prophylactic Human Vaccines Product and Service

    • 14.7 Altimmune

      • 14.7.1 Altimmune Company Details

      • 14.7.2 Altimmune Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Altimmune Prophylactic Human Vaccines Product and Service

    • 14.8 Bharat Biotech International

      • 14.8.1 Bharat Biotech International Company Details

      • 14.8.2 Bharat Biotech International Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bharat Biotech International Prophylactic Human Vaccines Product and Service

    • 14.9 Hualan Biological Engineering

      • 14.9.1 Hualan Biological Engineering Company Details

      • 14.9.2 Hualan Biological Engineering Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Hualan Biological Engineering Prophylactic Human Vaccines Product and Service

    • 14.10 Sanofi Pasteur

      • 14.10.1 Sanofi Pasteur Company Details

      • 14.10.2 Sanofi Pasteur Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Pasteur Prophylactic Human Vaccines Product and Service

    • 14.11 Janssen Pharmaceuticals

      • 14.11.1 Janssen Pharmaceuticals Company Details

      • 14.11.2 Janssen Pharmaceuticals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Janssen Pharmaceuticals Prophylactic Human Vaccines Product and Service

    • 14.12 BiondVax Pharmaceuticals

      • 14.12.1 BiondVax Pharmaceuticals Company Details

      • 14.12.2 BiondVax Pharmaceuticals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 BiondVax Pharmaceuticals Prophylactic Human Vaccines Product and Service

    • 14.13 MedImmune

      • 14.13.1 MedImmune Company Details

      • 14.13.2 MedImmune Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 MedImmune Prophylactic Human Vaccines Product and Service

    • 14.14 Merck

      • 14.14.1 Merck Company Details

      • 14.14.2 Merck Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Merck Prophylactic Human Vaccines Product and Service

    • 14.15 Seqirus

      • 14.15.1 Seqirus Company Details

      • 14.15.2 Seqirus Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Seqirus Prophylactic Human Vaccines Product and Service

    • 14.16 Zydus Cadila

      • 14.16.1 Zydus Cadila Company Details

      • 14.16.2 Zydus Cadila Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Zydus Cadila Prophylactic Human Vaccines Product and Service

    • 14.17 GlaxoSmithKline

      • 14.17.1 GlaxoSmithKline Company Details

      • 14.17.2 GlaxoSmithKline Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 GlaxoSmithKline Prophylactic Human Vaccines Product and Service

    • 14.18 SK Chemicals

      • 14.18.1 SK Chemicals Company Details

      • 14.18.2 SK Chemicals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 SK Chemicals Prophylactic Human Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Prophylactic Human Vaccines

    • Figure Prophylactic Human Vaccines Picture

    • Table Global Prophylactic Human Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prophylactic Human Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prophylactic Human Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Prophylactic Human Vaccines Consumption by Country (2017-2022)

    • Figure United States Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prophylactic Human Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Prophylactic Human Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prophylactic Human Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type I Consumption and Growth Rate (2017-2022)

    • Figure Global Type II Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Prophylactic Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Prophylactic Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Type I Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type II Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Prophylactic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Prophylactic Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Prophylactic Human Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Prophylactic Human Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table ALK (Foundation Year, Company Profile and etc.)

    • Table ALK Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALK Prophylactic Human Vaccines Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Prophylactic Human Vaccines Product and Service

    • Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Prophylactic Human Vaccines Product and Service

    • Table Bavarian Nordic (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Prophylactic Human Vaccines Product and Service

    • Table Shanghai BravoBio (Foundation Year, Company Profile and etc.)

    • Table Shanghai BravoBio Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai BravoBio Prophylactic Human Vaccines Product and Service

    • Table Serum Institute of India (Foundation Year, Company Profile and etc.)

    • Table Serum Institute of India Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Prophylactic Human Vaccines Product and Service

    • Table Altimmune (Foundation Year, Company Profile and etc.)

    • Table Altimmune Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Altimmune Prophylactic Human Vaccines Product and Service

    • Table Bharat Biotech International (Foundation Year, Company Profile and etc.)

    • Table Bharat Biotech International Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotech International Prophylactic Human Vaccines Product and Service

    • Table Hualan Biological Engineering (Foundation Year, Company Profile and etc.)

    • Table Hualan Biological Engineering Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Prophylactic Human Vaccines Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Prophylactic Human Vaccines Product and Service

    • Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Prophylactic Human Vaccines Product and Service

    • Table BiondVax Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table BiondVax Pharmaceuticals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BiondVax Pharmaceuticals Prophylactic Human Vaccines Product and Service

    • Table MedImmune (Foundation Year, Company Profile and etc.)

    • Table MedImmune Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune Prophylactic Human Vaccines Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Prophylactic Human Vaccines Product and Service

    • Table Seqirus (Foundation Year, Company Profile and etc.)

    • Table Seqirus Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seqirus Prophylactic Human Vaccines Product and Service

    • Table Zydus Cadila (Foundation Year, Company Profile and etc.)

    • Table Zydus Cadila Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zydus Cadila Prophylactic Human Vaccines Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Prophylactic Human Vaccines Product and Service

    • Table SK Chemicals (Foundation Year, Company Profile and etc.)

    • Table SK Chemicals Prophylactic Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Chemicals Prophylactic Human Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.